IL98810A - Pharmaceuticals containing flopirtin against disorders of muscle tension and their preparation - Google Patents
Pharmaceuticals containing flopirtin against disorders of muscle tension and their preparationInfo
- Publication number
- IL98810A IL98810A IL9881091A IL9881091A IL98810A IL 98810 A IL98810 A IL 98810A IL 9881091 A IL9881091 A IL 9881091A IL 9881091 A IL9881091 A IL 9881091A IL 98810 A IL98810 A IL 98810A
- Authority
- IL
- Israel
- Prior art keywords
- optionally
- flupirtine
- disorders
- preparation
- muscular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pyrrole Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Golf Clubs (AREA)
- Details Of Television Scanning (AREA)
- Paints Or Removers (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4022442 | 1990-07-14 | ||
IN421CA1991 IN172468B (fr) | 1990-07-14 | 1991-06-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL98810A0 IL98810A0 (en) | 1992-07-15 |
IL98810A true IL98810A (en) | 1996-01-19 |
Family
ID=25895002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9881091A IL98810A (en) | 1990-07-14 | 1991-07-12 | Pharmaceuticals containing flopirtin against disorders of muscle tension and their preparation |
Country Status (30)
Country | Link |
---|---|
US (2) | US5162346A (fr) |
EP (2) | EP0659410B1 (fr) |
KR (1) | KR0182811B1 (fr) |
CN (1) | CN1070700C (fr) |
AT (2) | ATE133564T1 (fr) |
AU (1) | AU634073B2 (fr) |
CA (1) | CA2046943C (fr) |
CZ (1) | CZ280879B6 (fr) |
DE (3) | DE59107331D1 (fr) |
DK (2) | DK0659410T3 (fr) |
EG (1) | EG19814A (fr) |
ES (2) | ES2164111T3 (fr) |
GR (1) | GR3019179T3 (fr) |
HR (1) | HRP920667B1 (fr) |
HU (1) | HU206973B (fr) |
IE (1) | IE74688B1 (fr) |
IL (1) | IL98810A (fr) |
IN (1) | IN172468B (fr) |
LT (1) | LT3593B (fr) |
LV (1) | LV10048B (fr) |
MC (1) | MC2272A1 (fr) |
MX (1) | MX9100160A (fr) |
NO (1) | NO912758L (fr) |
NZ (1) | NZ238940A (fr) |
PT (1) | PT98291B (fr) |
RO (1) | RO108220B1 (fr) |
RU (1) | RU2070408C1 (fr) |
SI (1) | SI9111227B (fr) |
SK (1) | SK279567B6 (fr) |
ZA (1) | ZA915466B (fr) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2111659T3 (es) * | 1992-03-11 | 1998-03-16 | Asta Medica Ag | Comprimidos, granulados y nodulos con alto contenido en sustancias activas para formas de administracion solidas de alta concentracion. |
DE4319649A1 (de) * | 1993-03-18 | 1994-09-22 | Asta Medica Ag | Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe |
DE4327516A1 (de) * | 1993-08-17 | 1995-02-23 | Asta Medica Ag | Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin |
GB9426079D0 (en) * | 1994-12-23 | 1995-02-22 | Orion Yhtymae Oy | A gelatine capsule |
DE19541405A1 (de) * | 1995-11-07 | 1997-05-15 | Asta Medica Ag | Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen |
US6284794B1 (en) | 1996-11-05 | 2001-09-04 | Head Explorer Aps | Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase |
US6610324B2 (en) * | 1999-04-07 | 2003-08-26 | The Mclean Hospital Corporation | Flupirtine in the treatment of fibromyalgia and related conditions |
JP2003530308A (ja) * | 1999-08-03 | 2003-10-14 | アーヴェーデー.ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディートゲゼルシャフト | 犬および猫の退行性関節疾患に起因する痛みを軽減するためのフルピルチンの使用 |
US6821995B1 (en) | 1999-12-01 | 2004-11-23 | Duke University | Method of treating batten disease |
US20040122090A1 (en) * | 2001-12-07 | 2004-06-24 | Lipton Stuart A. | Methods for treating neuropsychiatric disorders with nmda receptor antagonists |
RU2213565C1 (ru) * | 2002-06-24 | 2003-10-10 | Общество с ограниченной ответственностью "Паркинфарм" | Способ лечебного воздействия на организм пациента при лечении болезни паркинсона |
DE10255415A1 (de) * | 2002-11-28 | 2004-06-09 | Bayer Healthcare Ag | Dermale Applikation von Flupirtin |
DE10327674A1 (de) | 2003-06-20 | 2005-01-05 | Awd.Pharma Gmbh & Co. Kg | Injizierbare Darreichungsform von Flupirtin |
US20050089559A1 (en) * | 2003-10-23 | 2005-04-28 | Istvan Szelenyi | Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
DE102004001558A1 (de) * | 2004-01-10 | 2005-08-18 | Bayer Healthcare Ag | Arzneimittel zur topischen Applikation bei Tieren |
US20050196461A1 (en) * | 2004-01-14 | 2005-09-08 | Udell Ronald G. | Ceramide formulations suitable for oral administration |
KR20060124731A (ko) * | 2004-01-29 | 2006-12-05 | 뉴로몰레큘라 파마슈티칼스, 인코포레이티드 | 중추신경계-관련 질환 치료용 nmda 수용체 길항제 및mao-억제제 또는 gadph-억제제의 배합물 |
US20050220862A1 (en) * | 2004-03-31 | 2005-10-06 | Bernstein Joel E | Compositions with reduced hepatotoxicity |
US7619007B2 (en) | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
EP1688141A1 (fr) * | 2005-01-31 | 2006-08-09 | elbion AG | Utilisation de flupirtine pour le traitement de la vessie hyperactive et des maladies associées et pour le traitement du syndrome du colon irritable |
CA2604052C (fr) | 2005-04-06 | 2014-07-08 | Adamas Pharmaceuticals, Inc. | Methode et compositions de traitement des affections du snc |
CA2650853A1 (fr) * | 2006-05-02 | 2007-11-15 | Chris Rundfeldt | Activateurs de canaux potassiques pour la prevention et le traitement de la dystonie et des systemes assimiles a la dystonie |
US7960436B2 (en) * | 2006-06-05 | 2011-06-14 | Valeant Pharmaceuticals International | Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators |
US8993593B2 (en) * | 2006-08-23 | 2015-03-31 | Valeant Pharmaceuticals International | N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators |
KR20090079191A (ko) * | 2006-08-23 | 2009-07-21 | 밸리언트 파마슈티컬즈 인터내셔널 | 칼륨 채널 조절제로서 4-(n-아자사이클로알킬) 아닐리드의 유도체 |
US8722929B2 (en) * | 2006-10-10 | 2014-05-13 | Valeant Pharmaceuticals International | N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators |
CN101578259A (zh) * | 2006-11-28 | 2009-11-11 | 威朗国际制药公司 | 作为钾通道调节剂的1,4-二氨基双环瑞替加滨类似物 |
US20080279930A1 (en) * | 2007-05-07 | 2008-11-13 | Bernd Terhaag | Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof |
US8367684B2 (en) * | 2007-06-13 | 2013-02-05 | Valeant Pharmaceuticals International | Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators |
US8563566B2 (en) * | 2007-08-01 | 2013-10-22 | Valeant Pharmaceuticals International | Naphthyridine derivatives as potassium channel modulators |
MX2010001171A (es) * | 2007-08-01 | 2010-03-01 | Lundbeck & Co As H | Uso de abridores de canales de potasio kcnq para reducir los sintomas o tratar desordenes o afecciones en las cuales se encuentra anulado el sistema dopaminergico. |
US7786146B2 (en) * | 2007-08-13 | 2010-08-31 | Valeant Pharmaceuticals International | Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
ES2347119B2 (es) * | 2009-04-22 | 2011-04-28 | Universidad De Santiago De Compostela | Nanocapsulas de poliarginina. |
DE102010030053A1 (de) | 2010-06-14 | 2011-12-15 | Awd.Pharma Gmbh & Co.Kg | Injizierbare Darreichungsform von Flupirtin |
JP6251667B2 (ja) * | 2014-06-03 | 2017-12-20 | アサヒカルピスウェルネス株式会社 | 錠剤型即放性製剤及びその製造方法 |
DE102017007385A1 (de) | 2017-08-02 | 2019-02-07 | Christoph Hoock | Maleatfreie feste Arzneimittelformen |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1795858C2 (de) | 1968-07-19 | 1979-01-11 | Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt | Benzylaminopyridine |
DE3133519A1 (de) | 1980-09-13 | 1982-06-09 | Degussa Ag, 6000 Frankfurt | "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat" |
ATE46265T1 (de) * | 1985-01-23 | 1989-09-15 | Asta Pharma Ag | Synergistische kombination von flupirtin und nicht-steroidalen antiphlogistika. |
DE3604575A1 (de) * | 1985-02-23 | 1986-08-28 | Degussa Ag, 6000 Frankfurt | Kombination von flupirtin und anticholinergisch wirkenden spasmolytika |
DE3663775D1 (en) * | 1985-02-23 | 1989-07-13 | Asta Pharma Ag | Combination of flupirtin with spasmolytics having an anticholinergic effect |
FI855016A (fi) * | 1985-06-28 | 1986-12-29 | Degussa | Synergistisk kombination av flupirtin och 4-acetamido-fenol. |
-
1991
- 1991-06-04 IN IN421CA1991 patent/IN172468B/en unknown
- 1991-07-04 DK DK95101189T patent/DK0659410T3/da active
- 1991-07-04 ES ES95101189T patent/ES2164111T3/es not_active Expired - Lifetime
- 1991-07-04 EP EP95101189A patent/EP0659410B1/fr not_active Expired - Lifetime
- 1991-07-04 ES ES91111124T patent/ES2082887T3/es not_active Expired - Lifetime
- 1991-07-04 DK DK91111124.3T patent/DK0467164T3/da active
- 1991-07-04 AT AT91111124T patent/ATE133564T1/de not_active IP Right Cessation
- 1991-07-04 EP EP91111124A patent/EP0467164B1/fr not_active Expired - Lifetime
- 1991-07-04 AT AT95101189T patent/ATE206919T1/de not_active IP Right Cessation
- 1991-07-04 DE DE59107331T patent/DE59107331D1/de not_active Expired - Lifetime
- 1991-07-04 DE DE4122166A patent/DE4122166A1/de not_active Ceased
- 1991-07-04 DE DE59109222T patent/DE59109222D1/de not_active Expired - Lifetime
- 1991-07-05 MC MC912203A patent/MC2272A1/fr unknown
- 1991-07-08 SK SK2101-91A patent/SK279567B6/sk not_active IP Right Cessation
- 1991-07-08 CZ CS912101A patent/CZ280879B6/cs not_active IP Right Cessation
- 1991-07-09 RO RO147972A patent/RO108220B1/ro unknown
- 1991-07-09 EG EG41291A patent/EG19814A/xx active
- 1991-07-10 MX MX9100160A patent/MX9100160A/es unknown
- 1991-07-10 US US07/726,408 patent/US5162346A/en not_active Expired - Lifetime
- 1991-07-11 PT PT98291A patent/PT98291B/pt not_active IP Right Cessation
- 1991-07-12 IE IE245191A patent/IE74688B1/en not_active IP Right Cessation
- 1991-07-12 RU SU915001150A patent/RU2070408C1/ru active
- 1991-07-12 HU HU912359A patent/HU206973B/hu unknown
- 1991-07-12 SI SI9111227A patent/SI9111227B/sl unknown
- 1991-07-12 AU AU80403/91A patent/AU634073B2/en not_active Expired
- 1991-07-12 NZ NZ238940A patent/NZ238940A/en not_active IP Right Cessation
- 1991-07-12 IL IL9881091A patent/IL98810A/en not_active IP Right Cessation
- 1991-07-12 CA CA002046943A patent/CA2046943C/fr not_active Expired - Lifetime
- 1991-07-12 NO NO91912758A patent/NO912758L/no unknown
- 1991-07-12 ZA ZA915466A patent/ZA915466B/xx unknown
- 1991-07-13 KR KR1019910011967A patent/KR0182811B1/ko not_active IP Right Cessation
- 1991-07-13 CN CN91104030A patent/CN1070700C/zh not_active Expired - Lifetime
-
1992
- 1992-06-01 US US07/890,730 patent/US5284861A/en not_active Expired - Lifetime
- 1992-09-30 HR HRP-1227/91A patent/HRP920667B1/xx not_active IP Right Cessation
- 1992-10-27 LV LVP-92-173A patent/LV10048B/lv unknown
-
1993
- 1993-09-03 LT LTIP919A patent/LT3593B/lt not_active IP Right Cessation
-
1996
- 1996-03-05 GR GR960400581T patent/GR3019179T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2046943C (fr) | Procede de production d'un agent ayant comme substance active de la flupirtine et visant a soulager la tension musculaire | |
AU622276B2 (en) | Medicament containing dihydrolipoic acid as active substance | |
US4812481A (en) | Synergistic combination of amantadiene and selegiline | |
CA2007480C (fr) | Utilisation d'une substance active, l'azelastine pour le traitement du psoriasis et des inflammations | |
AU601237B2 (en) | The use of paroxetine to treat pain | |
US5068233A (en) | Synergistic combination of azelastine and theophylline or azelastine and α-mimetics | |
US4839384A (en) | Method of inhibiting onset of or treating migraine headache using a thromboxane A2 receptor antagonist | |
JPH06511231A (ja) | 2−(ピロリジニル−1−メチル)−ピペリジン誘導体およびκ受容体アゴニストとしてのその使用 | |
US5290769A (en) | Use of hexadecylphosphocholine for the treatment of psoriasis | |
JPH0525167A (ja) | 緑内障の治療に有用な置換ベンゼン誘導体 | |
US6046200A (en) | Compositions having neuroprotective and analgesic activity | |
ITRM940322A1 (it) | "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione ed applicazione". | |
JPH01199914A (ja) | 妊娠毒血症の予防または治療用組成物 | |
KR20010021796A (ko) | 선택성 세로토닌 재흡수 억제제 (ssri)를 사용하는심장 질환의 치료 및 예방법 | |
PT95422B (pt) | Processo para a preparacao de composicoes farmaceuticas para o tratamento de psoriase incorporando compostos de acidos alquilfosforicos | |
JP3141051B2 (ja) | 抗動脈硬化剤 | |
JPH0532627A (ja) | 筋肉痙攣により帰因するか又は筋肉痙攣の結果である疾病及び症候群を治療するための医薬品及びその製法 | |
JPS6026770B2 (ja) | 消化管潰瘍治療剤 | |
NZ232059A (en) | Compositions and use of an alkyl glycerine and azelastine: (4-(p-chlorobenzyl)-2-(hexahydro-1-methyl-1h-azepine-4-yl)-1(2h)-phthalazinone; preparatory processes | |
IE84029B1 (en) | Use of the compound flupirtin for the preparation of a medicament against muscle bracing | |
JPH02200632A (ja) | 医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |